Richard G. Moran - Concepedia

Author

Richard G. Moran

Virginia Commonwealth University

Also Known As

R G Moran, Richard G Moran, Richard G. Moran, Richard Moran

158

Publications

6.4K

Citations

H-Index

121

Concepts

All Affiliations

Virginia Commonwealth University Virginia Commonwealth University Medical Center University of Southern California Children's Hospital of Los Angeles Dana-Farber Cancer Institute

About

Richard G. Moran is an author at Virginia Commonwealth University specializing in medicine, natural sciences, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	24	2K
2	Law	4	4	123
3	Engineering	1	1	28
4	Humanities	1	1	25
5	Language Studies	1	1	44

Richard G. Moran

Publications

Citations

H-Index

Page 1

	Year	Citations
DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria Lisa S. Shock, Prashant V. Thakkar, Erica J. Peterson, Proceedings of the National Academy of Sciences DnaEpigenetic ChangeGeneticsDna MethylationMolecular Biology	2011	535
In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas. Colin Paul Spears, Antranik Shahinian, Richard G. Moran, PubMed Tumor BiologyVivo KineticsThymidylate Synthetase InhibitionMedicinePharmacology	1982	256
A dideazatetrahydrofolate analog lacking a chiral center at C-6: N-[4-[2-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-5yl)ethyl[benzoyl]-L-glutamic acid is an inhibitor of thymidylate synthase Edward C. Taylor, Dietmar Kuhnt, Chuan Shih, Journal of Medicinal Chemistry	1992	252
Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells. Khandan Keyomarsi, Richard G. Moran PubMed Molecular PharmacologyChemoprevention StrategyBiochemistryHuman Leukemic CellsMedicine	1986	161
Synthesis of the antileukemic agents 5,10-dideazaaminopterin and 5,10-dideaza-5,6,7,8-tetrahydroaminopterin Edward C. Taylor, Peter J. Harrington, Stephen R. Fletcher, Journal of Medicinal Chemistry	1985	148
Therapeutics by Cytotoxic Metabolite Accumulation: Pemetrexed Causes ZMP Accumulation, AMPK Activation, and Mammalian Target of Rapamycin Inhibition Alexandra C. Racanelli, Scott B. Rothbart, Cortney L. Heyer, Cancer Research	2009	144
Retrovirally Mediated Complementation of the glyBPhenotype Steven A. Titus, Richard G. Moran Journal of Biological Chemistry Glyb CellsSequence Tag DatabaseGeneticsImmunologyGlycobiology	2000	129
Biochemical determinants of tumor sensitivity to 5-fluorouracil: Ultrasensitive methods for the determination of 5-fluoro-2′-deoxyuridylate, 2′-deoxyuridylate, and thymidylate synthetase Richard G. Moran, Colin Paul Spears, Charles Heidelberger Proceedings of the National Academy of Sciences	1979	121
Folate Metabolism in Plants Mariette Bedhomme, Michaela Hoffmann, Erin McCarthy, Journal of Biological Chemistry BotanyGeneticsEscherichia ColiPlant BiochemistryMolecular Genetics	2005	116
Sorafenib Enhances Pemetrexed Cytotoxicity through an Autophagy-Dependent Mechanism in Cancer Cells M. Danielle Bareford, Margaret A. Park, Adly Yacoub, Cancer Research MitophagyChemoprevention StrategyImmunologyCell DeathCancer Biology	2011	108

Page 1